MedPath

Effect of Single Dose of 2L PEG on Bowel Preparation in Average-risk Patients Undergoing Colonoscopy

Not Applicable
Completed
Conditions
Health Behavior
Interventions
Drug: Split dose of 4L PEG
Drug: Single dose of 2L PEG
Registration Number
NCT02998255
Lead Sponsor
Air Force Military Medical University, China
Brief Summary

Adequate quality of bowel preparation(BP) is important for colonoscopy. Several guidelines recommend that split-dose of 4L PEG should be used as a standard regime for BP. However, the high-volume PEG still results in lower compliance to the regime and increased cost.

Some high risk factors for inadequate BP have been identified, including old age, constipation, diabetes, the use of narcotics and prior history of inadequate BP. For average-risk patients without the high risk factors, the procedure of BP could be easier. In the previous study, with the use of single dose of 2L PEG, more than 90% of average-risk patients achieved adequate BP. Here investigators hypothesized that compared with the standard split dose of 4L PEG, single dose of 2L PEG may be not inferior in BP quality while may be accompanied with better tolerability.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
940
Inclusion Criteria
  • Patients undergoing colonoscopy;

  • Patients with average risks for inadequate BP (Patients were identified average-risk if they did not meet any factor of the following risk factors):

    • Constipation
    • Diabetes
    • Parkinson's disease
    • History of stroke or spine cord injure
    • Prior history of inadequate bowel preparation
    • BMI>25
    • Use of tricyclic antidepressant or narcotics
Exclusion Criteria
  • History of colorectal resection;
  • Suspected colonic stricture or perforation;
  • Incomplete or complete bowel obstruction;
  • Use of prokinetic agents or purgatives within 7 days;
  • Toxic colitis or megacolon;
  • Pregnancy or lactation;
  • Unable to give informed consent;
  • Haemodynamically unstable.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Split-dose of 4L PEGSplit dose of 4L PEGSplit-dose of 4l PEG was used before and on the day of colonoscopy
Single dose of 2L PEGSingle dose of 2L PEG2 L of PEG solution was used on the day of colonoscopy.
Primary Outcome Measures
NameTimeMethod
Rate of adequate bowel preparation(defined as a total BostonBowel Preparation Score ≥6 with each segmental BBPS≥2)1 year

The adequacy of bowel preparation is defined as Boston Bowel Preparation Scale (BBPS), a 4-point scoring system applied to each of 3 broad regions of the colon: the right side, the transverse section, and the left side. They were summed to give the total BBPS score, which ranged from 0 to 9.The withdrawal procedure was recorded by vedios. The BBPS and segmental scores in each segment were judged by one endoscopist who was familiar with the criteria of BBPS and blinded to group allocation.

Secondary Outcome Measures
NameTimeMethod
Polyp detection rate1 year
Cecal intubation time1 year
Withdrawal time1 year
Rate of adverse events1 year

adverse events, such as vomiting, nausea, headache, abdominal pain

Cecal intubation rate1 year
Willingness to repeat bowel preparation1 year

The number of patients have a willingness to undergo a repeated bowel preparation if needed

Trial Locations

Locations (3)

Department of gastroenterology, Qinghai Provincial People's Hospital

🇨🇳

Xining, Qinghai, China

Department of gastroenterology, Shaanxi Second People's Hospital

🇨🇳

Xi'an, Shaanxi, China

Endoscopic center, Xijing Hospital of Digestive Diseases

🇨🇳

Xi'an, Shanxi, China

© Copyright 2025. All Rights Reserved by MedPath